Passive Ceiling Light Disinfection System to Reduce Bioburden in an Intensive Care Unit

Abstract

A ceiling-installed narrow spectrum (402–420 nm) bactericidal blue light disinfection system was installed in a large suburban medical intensive care unit (ICU) and evaluated for implementation feasibility and effectiveness in reducing environmental bioburden. Installation of 54 ceiling devices was accomplished at low cost and with minimal ICU process disruption. Postinstallation high-touch surface colony counts were significantly lower than preinstallation. Linear mixed modeling demonstrated a 21% average overall decrease in colony count after installation, with consistent reduction in colony counts starting from week 4 postinstallation. Automated technology is potentially more efficient in reducing environmental bioburden in the acute care setting compared with other bioburden reducing methods or can provide a robust compliment to manual cleaning.

Keywords

bioburden - blue light technology - infection prevention - infection control - light therapy

• References

• 1 Coppin JD, Villamaria FC, Williams MD, Copeland LA, Zeber JE, Jinadatha C. Self-sanitizing copper-impregnated surfaces for bioburden reduction in patient rooms. Am J Infect Control 2017; 45 (06) 692-694
• 2 Vincent JL, Rello J, Marshall J. , et al; EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302 (21) 2323-2329
• 3 Passaretti CL, Otter JA, Reich NG. , et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis 2013; 56 (01) 27-35
• 4 Russotto V, Cortegiani A, Raineri SM, Giarratano A. Bacterial contamination of inanimate surfaces and equipment in the intensive care unit. J Intensive Care 2015; 3: 54
• 5 Rohr U, Kaminski A, Wilhelm M, Jurzik L, Gatermann S, Muhr G. Colonization of patients and contamination of the patients' environment by MRSA under conditions of single-room isolation. Int J Hyg Environ Health 2009; 212 (02) 209-215
• 6 Dancer SJ. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev 2014; 27 (04) 665-690
• 7 Weber DJ, Rutala WA, Anderson DJ, Chen LF, Sickbert-Bennett EE, Boyce JM. Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: focus on clinical trials. Am J Infect Control 2016; 44 (5, Suppl): e77-e84
• 8 Yin R, Dai T, Avci P. , et al. Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol 2013; 13 (05) 731-762
• 9 Mégraud F, Lamouliatte H. Review article: the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 2003; 17 (11) 1333-1343
• 10 Maclean M, Booth MG, Anderson JG. , et al. Continuous decontamination of an intensive care isolation room during patient occupancy using 405 nm light technology. J Infect Prev 2013; 14 (05) 176-181
• 11 Rutala W, Kanamori H, Gergen M, Sickbert-Bennett E, Sexton D. Antimicrobial activity of a continuous visible light disinfection system. Open Forum Infect Dis 2016; 3 (Suppl. 01) 267
• 12 New York State Department of Health. Hospital-acquired infections in New York state, 2015, part 2: technical report. Available at: https://www.health.ny.gov/statistics/facilities/hospital/hospital_acquired_infections/20 15/docs/hospital_acquired_infection_p2.pdf . Accessed May 23, 2018
• 13 Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39 (02) 175-191